Personal tools

Coexpression cluster:C4289: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C4289_CD14_Eosinophils_Olfactory_Neutrophils_mucinous_Monocytederived_eye |id=C4289 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C4289_CD14_Eosinophils_Olfactory_Neutrophils_mucinous_Monocytederived_eye
|full_id=C4289_CD14_Eosinophils_Olfactory_Neutrophils_mucinous_Monocytederived_eye
|id=C4289
|id=C4289
|ontology_enrichment_celltype=CL:0000766!4.94e-30!76;CL:0000763!2.88e-26!112;CL:0000049!2.88e-26!112;CL:0000557!3.45e-26!71;CL:0002057!3.47e-25!42;CL:0002009!2.19e-24!65;CL:0000738!7.14e-24!140;CL:0002194!1.85e-23!63;CL:0000576!1.85e-23!63;CL:0000040!1.85e-23!63;CL:0000559!1.85e-23!63;CL:0000839!2.20e-23!70;CL:0000860!9.27e-23!45;CL:0002032!1.31e-21!165;CL:0000837!1.31e-21!165;CL:0000988!2.05e-21!182;CL:0000037!6.75e-21!172;CL:0000566!6.75e-21!172;CL:0002031!5.33e-18!124;CL:0002087!3.83e-17!119;CL:0000134!2.38e-09!358;CL:0002320!3.16e-09!365;CL:0000219!2.61e-07!390
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!1.02e-29!102;UBERON:0003061!1.02e-29!102;UBERON:0002193!2.51e-27!112;UBERON:0002371!2.79e-25!80;UBERON:0001474!1.28e-21!86;UBERON:0004765!1.86e-17!101;UBERON:0001434!1.86e-17!101;UBERON:0002405!1.72e-15!115;UBERON:0003081!7.88e-11!216;UBERON:0002384!5.72e-09!375
}}
}}

Revision as of 14:46, 21 May 2012


Full id: C4289_CD14_Eosinophils_Olfactory_Neutrophils_mucinous_Monocytederived_eye



Phase1 CAGE Peaks

Hg19::chr3:14444181..14444192,+p2@SLC6A6
Hg19::chr3:14512659..14512665,+p@chr3:14512659..14512665
+
Hg19::chr3:14526619..14526634,+p@chr3:14526619..14526634
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
myeloid leukocyte4.94e-3076
myeloid cell2.88e-26112
common myeloid progenitor2.88e-26112
granulocyte monocyte progenitor cell3.45e-2671
CD14-positive, CD16-negative classical monocyte3.47e-2542
macrophage dendritic cell progenitor2.19e-2465
leukocyte7.14e-24140
monopoietic cell1.85e-2363
monocyte1.85e-2363
monoblast1.85e-2363
promonocyte1.85e-2363
myeloid lineage restricted progenitor cell2.20e-2370
classical monocyte9.27e-2345
hematopoietic oligopotent progenitor cell1.31e-21165
hematopoietic multipotent progenitor cell1.31e-21165
hematopoietic cell2.05e-21182
hematopoietic stem cell6.75e-21172
angioblastic mesenchymal cell6.75e-21172
hematopoietic lineage restricted progenitor cell5.33e-18124
nongranular leukocyte3.83e-17119
mesenchymal cell2.38e-09358
connective tissue cell3.16e-09365
motile cell2.61e-07390
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.02e-29102
blood island1.02e-29102
hemolymphoid system2.51e-27112
bone marrow2.79e-2580
bone element1.28e-2186
skeletal element1.86e-17101
skeletal system1.86e-17101
immune system1.72e-15115
lateral plate mesoderm7.88e-11216
connective tissue5.72e-09375


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.